JangoMed’s mission is to rebalance hormones to improve our overall health and well being. We are developing cutting-edge regenerative stem cell products for the human market.
JangoMed is developing two products for the human market. The first product is an autologous mesenchymal stem cell (MSC) therapy that is sourced from the human patient, bioengineered into ovarian or testicular organoids and transplanted back into the patient. This product will integrate into and restore circulating sex hormone concentrations for the treatment of hypogonadism, osteoarthritis and Alzheimer’s disease. The second product is an allogeneic version of these organoids for treatment of the same conditions.